PT1251875E - Uttlizacao de agentes de contraste na preparacao de um agente de diagnostico para a visualizacao do lumen intestinal - Google Patents

Uttlizacao de agentes de contraste na preparacao de um agente de diagnostico para a visualizacao do lumen intestinal

Info

Publication number
PT1251875E
PT1251875E PT00993689T PT00993689T PT1251875E PT 1251875 E PT1251875 E PT 1251875E PT 00993689 T PT00993689 T PT 00993689T PT 00993689 T PT00993689 T PT 00993689T PT 1251875 E PT1251875 E PT 1251875E
Authority
PT
Portugal
Prior art keywords
contrast agents
uttlization
visualization
preparation
diagnostic agent
Prior art date
Application number
PT00993689T
Other languages
English (en)
Portuguese (pt)
Inventor
Michael V Knopp
Giesel Frederik
Von Tengg-Kobligk Hendrik
Radeleff Jannis
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT1999MI002735 external-priority patent/IT1315273B1/it
Priority claimed from IT2000MI000193A external-priority patent/IT1317816B1/it
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Publication of PT1251875E publication Critical patent/PT1251875E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
PT00993689T 1999-12-29 2000-12-21 Uttlizacao de agentes de contraste na preparacao de um agente de diagnostico para a visualizacao do lumen intestinal PT1251875E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002735 IT1315273B1 (it) 1999-12-29 1999-12-29 Imaging del colon mediante contrastografia.
IT2000MI000193A IT1317816B1 (it) 2000-02-08 2000-02-08 Imaging del colon mediante contrastografia.

Publications (1)

Publication Number Publication Date
PT1251875E true PT1251875E (pt) 2006-07-31

Family

ID=26331700

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00993689T PT1251875E (pt) 1999-12-29 2000-12-21 Uttlizacao de agentes de contraste na preparacao de um agente de diagnostico para a visualizacao do lumen intestinal

Country Status (12)

Country Link
US (1) US20030113267A1 (https=)
EP (1) EP1251875B1 (https=)
JP (1) JP4798919B2 (https=)
CN (1) CN1302814C (https=)
AT (1) ATE320272T1 (https=)
AU (1) AU2842901A (https=)
CY (1) CY1105456T1 (https=)
DE (1) DE60026743T2 (https=)
DK (1) DK1251875T3 (https=)
ES (1) ES2259299T3 (https=)
PT (1) PT1251875E (https=)
WO (1) WO2001049326A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7606347B2 (en) * 2004-09-13 2009-10-20 General Electric Company Photon counting x-ray detector with overrange logic control
US7260174B2 (en) 2004-09-13 2007-08-21 General Electric Company Direct conversion energy discriminating CT detector with over-ranging correction
US7599465B2 (en) 2004-11-19 2009-10-06 General Electric Company Detection of thrombi in CT using energy discrimination
US7209536B2 (en) * 2004-11-19 2007-04-24 General Electric Company CT colonography system
US7583779B2 (en) * 2004-11-24 2009-09-01 General Electric Company System and method for acquisition and reconstruction of contrast-enhanced, artifact-reduced CT images
US7382853B2 (en) * 2004-11-24 2008-06-03 General Electric Company Method and system of CT data correction
US7613274B2 (en) * 2007-11-16 2009-11-03 General Electric Company Method and system of energy integrating and photon counting using layered photon counting detector
ES2955349T3 (es) * 2019-09-18 2023-11-30 Bayer Ag Predicción de imágenes MRI mediante un modelo de predicción entrenado por aprendizaje supervisado
JP7587575B2 (ja) * 2019-10-08 2024-11-20 バイエル、アクチエンゲゼルシャフト コントラスト強調のない肝臓のｍｒｉ画像の生成

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999445A (en) * 1988-06-10 1991-03-12 The Regents Of The University Of California Contrast agents for magnetic resonance imaging of the small intestine and hepatobiliary system
US5695739A (en) * 1989-06-30 1997-12-09 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
US6039931A (en) * 1989-06-30 2000-03-21 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5245282A (en) * 1991-06-28 1993-09-14 University Of Virginia Alumni Patents Foundation Three-dimensional magnetic resonance imaging
WO1993003351A1 (en) * 1991-08-09 1993-02-18 The Regents Of The University Of California Amino acid, ester and/or catechol contrast agents for mri
IT1252145B (it) * 1991-11-29 1995-06-05 Bracco Ind Chimica Spa Metodo e formulazioni adatte a migliorare lo studio degli organi cavi nell'uomo
WO1993015093A1 (en) * 1992-01-29 1993-08-05 The Regents Of The University Of California Specific contrast agents for magnetic resonance imaging of the small intestine and hepatobiliary system
US5401493A (en) * 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same
IT1269839B (it) * 1994-05-26 1997-04-15 Bracco Spa Coniugati di acidi biliari, loro derivati con complessi metallici e relativi usi
JP4432000B2 (ja) * 1996-12-23 2010-03-17 ブラッコ・リサーチ・ソシエテ・アノニム 患者の消化管の視覚化におけるｍｒｉ造影の増加用組成物

Also Published As

Publication number Publication date
WO2001049326A1 (en) 2001-07-12
ATE320272T1 (de) 2006-04-15
DK1251875T3 (da) 2006-07-24
EP1251875B1 (en) 2006-03-15
EP1251875A1 (en) 2002-10-30
US20030113267A1 (en) 2003-06-19
JP2003519200A (ja) 2003-06-17
DE60026743D1 (de) 2006-05-11
DE60026743T2 (de) 2006-08-17
CY1105456T1 (el) 2010-04-28
JP4798919B2 (ja) 2011-10-19
AU2842901A (en) 2001-07-16
ES2259299T3 (es) 2006-10-01
CN1413119A (zh) 2003-04-23
CN1302814C (zh) 2007-03-07

Similar Documents

Publication Publication Date Title
BR0103256A (pt) Utilização de substâncias bioquìmicas para uma composição para a prevenção e tratamento de condições de saúde causadas por constrição de células de músculo liso em órgãos do corpo humano
DE60142075D1 (de) Stentvorrichtungen mit abtrennbaren proximalen und distalen drähten
EP1671575A4 (en) INSTRUMENT FOR EXAMINING THE INTERIOR OF A DIGESTIVE TRACT
BR0110748A (pt) Plataforma de nanodispositivo multifuncional
NO20014769D0 (no) Preparat for behandling og diagnose av bryst cancer og fremgangsmåter for anvendelse derav
BR0115150A (pt) Radiofarmacêuticos para diagnosticar doença de alzheimer
EA200000814A1 (ru) Фармацевтическая композиция топирамата
BR0208446A (pt) Agentes terapêuticos para doenças inflamatórias do intestino
NO20064676L (no) Farmasoytiske salter av 3-0-(3'3'-dimetylsuccinyl)betulinsyre
DE50014699D1 (de) Medizinisches Instrument zum Präparieren von Gewebe
FR2753897B1 (fr) Dispositif pour le diagnostic endoscopique photodynamique de tissu tumoral
WO2001092283A3 (en) Cobalamin compounds useful as cardiovascular agents and as imaging agents
AU6408901A (en) Early diagnosis of conformational diseases
EP1516049A4 (en) COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
PT1251875E (pt) Uttlizacao de agentes de contraste na preparacao de um agente de diagnostico para a visualizacao do lumen intestinal
PT1339407E (pt) Inibidores da proteina farnesil transferase para o tratamento de doenca inflamatoria do intestino
BR0009211A (pt) Derivados de resorcinol
EP1420814A4 (en) COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
DE60207612D1 (de) Verbindungen zur bilddarstellung der alzheimer-krankenheit
NO20076119L (no) Diagnostisk markor for diabetiske vaskulaere komplikasjoner
IL150623A0 (en) Measurement system for examining a section of tissue on a patient and the use of a measurement system of this type
WO2007066119A3 (en) Novel imaging agents for fibrosis
HUP0101514A2 (hu) Készítmény és eljárás gyulladásos bélbetegség kezelésére N-acetilglükózamin vastagbélbe történő adagolásával
ES2126913T3 (es) Agente de ecocontraste oral para el diagnostico por ultrasonidos.
ATE337020T1 (de) Fettsaure analoge zur diagnose von kranzarterie erkrankungen